Natural killer cells mixture (NKBio Biopharmacology)

N/A

Report date: 2022/09/23 10:26:18

Base Information

Drug NameNatural killer cells mixture (NKBio Biopharmacology)
Drug Alias NameNKM
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells stimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma
Global Approved IndicationsLymphoma
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2007/08/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNkbio Biopharmacology
China Registration ClassN/A

Develop Information

Active CompaniesNkbio Biopharmacology
Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeV03AX
Related LinksN/A